Literature DB >> 10594486

Effects of bupivacaine on human erythrocytes submitted to stress and evidence for an interaction between bupivacaine and flumazenil.

F Lenfant1, J J Lahet, F Volot, I Schafer, M Freysz, L Rochette.   

Abstract

AIMS: To examine the effects of bupivacaine on erythrocytes submitted to an oxidative stress (AAPH) and to provide evidence for an in vitro interaction between bupivacaine and flumazenil.
METHODS: Human erythrocytes were studied with or without AAPH in the presence of different concentrations of bupivacaine (0.15, 0.3, 0.9 and 1.8 mmol l-1 ), or flumazenil (0.16 mmol l-1 ) and with the association of flumazenil and two doses of bupivacaine (0.15 and 0.3 mmol l-1 ). Potassium efflux was measured by flame photometry at T0, and every 30 min for 2 h.
RESULTS: In the absence of AAPH, extracellular potassium remained unchanged. Oxidative stress induced a significant increase in extracellular potassium, which was not modified by incubation with flumazenil. Bupivacaine significantly lowered the increase in extracellular potassium in a dose-related fashion. The association with flumazenil blunted the effects of bupivacaine. Discussion In this model, bupivacaine proved effective in protecting erythrocytes against oxidative stress. Flumazenil interacted with bupivacaine and blunted its protective effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594486      PMCID: PMC2014309          DOI: 10.1046/j.1365-2125.1999.00083.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Local anesthetic-induced toxicity may be modified by low doses of flumazenil.

Authors:  B Bruguerolle; N Emperaire
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

2.  Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics.

Authors:  F Sztark; M Malgat; P Dabadie; J P Mazat
Journal:  Anesthesiology       Date:  1998-05       Impact factor: 7.892

3.  [Systemic toxicity of local anesthetics. Pharmacokinetic and pharmacodynamic factors].

Authors:  M Freysz; J L Béal; Q Timour; L Bertrix; G Faucon
Journal:  Ann Fr Anesth Reanim       Date:  1988

Review 4.  The membrane actions of anesthetics and tranquilizers.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1972-12       Impact factor: 25.468

5.  Lack of bupivacaine kinetic changes induced by flumazenil in mice.

Authors:  B Bruguerolle; A M Lorec
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

6.  Peroxyl radical-mediated hemolysis: role of lipid, protein and sulfhydryl oxidation.

Authors:  I S Sandhu; K Ware; M B Grisham
Journal:  Free Radic Res Commun       Date:  1992

7.  In vitro study on antioxidant potential of various drugs used in the perioperative period.

Authors:  M Y Kang; M Tsuchiya; L Packer; M Manabe
Journal:  Acta Anaesthesiol Scand       Date:  1998-01       Impact factor: 2.105

Review 8.  Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use.

Authors:  R N Brogden; K L Goa
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  Effects of nitric oxide on red blood cells: changes in erythrocyte resistance to hypotonic hemolysis and potassium efflux by experimental maneuvers that decrease nitric oxide.

Authors:  C Caramelo; A Riesco; J Outeiriño; I Millás; G Blum; B Monzú; V Casado; L Sánchez; J R Mosquera; S Casado
Journal:  Biochem Biophys Res Commun       Date:  1994-03-15       Impact factor: 3.575

10.  [Does flumazenil correct disorders of intracardiac conduction induced by accidental intravenous injection of bupivacaine?].

Authors:  F Lenfant; F Volot; M Freysz; M Wilkening
Journal:  Ann Fr Anesth Reanim       Date:  1996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.